Medicare Limits Coverage of Aduhelm to Patients in Clinical Trials
Regulation
Medicare Limits Coverage of Aduhelm to Patients in Clinical Trials
2022-04-07 22:17:02
by Dan McCue

WASHINGTON — Despite pressure to go another way, Medicare on Thursday evening announced it will only cover the new Alzheimer’s disease drug Aduhelm for people participating in a clinical trial. The decision came as something of a surprise as Medicare... Read More

FDA Changes Prescribing Instructions for Controversial Alzheimer’s Drug
Prescription Drugs
FDA Changes Prescribing Instructions for Controversial Alzheimer’s Drug
2021-07-08 17:38:20
by Dan McCue

U.S. health regulators on Thursday approved new prescribing instructions that are likely to limit use of a controversial new Alzheimer’s drug. The announcement came through Biogen Inc., the maker of Aduhelm, which stated the update is intended to “clarify” the... Read More

Straight From The Well
scroll top